Kbc Private Partners Life Sciences (PRIVAK) (SComm)

Active

VAT

BE 0769.268.990

Address

Avenue du Port 2

1080 Molenbeek-Saint-Jean

Established

02-06-2021

Principal activity

Trusts, funds and similar financial entities

Try for free

Crisis resilience of Kbc Private Partners Life Sciences (PRIVAK)

Which companies are best armed against current economic trends and the energy crisis?

2023		2022
Profit/Loss	-€16,120	28%	-€22,372
Equity	€13,986,508	67%	€8,392,628
Gross margin	-€7,831	13%	-€8,975

Publications in the Belgian Official Journal for Kbc Private Partners Life Sciences (PRIVAK)

Type	Date	Pdf	Subject
	22-11-2024		Modification(s) Articles of Association (NL)
	27-06-2024		Capital - Shares (NL)
	16-11-2021		Articles of Association (Translation, Coordination, Other Modifications, …) (NL)
	19-10-2021		Articles of Association (Translation, Coordination, Other Modifications, …) (NL)
	04-06-2021		Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Sources

Frequently asked questions

What is the VAT number of Kbc Private Partners Life Sciences (PRIVAK)?

The VAT number of Kbc Private Partners Life Sciences (PRIVAK) is BE0769268990.

When was Kbc Private Partners Life Sciences (PRIVAK) founded?

Kbc Private Partners Life Sciences (PRIVAK) was founded on 02-06-2021.

What is the address of Kbc Private Partners Life Sciences (PRIVAK)?

The current registered office of Kbc Private Partners Life Sciences (PRIVAK) is located at Avenue du Port 2, 1080 Molenbeek-Saint-Jean.

When was the last time Kbc Private Partners Life Sciences (PRIVAK) filed their annual financial statements?

The most recent financial statements of Kbc Private Partners Life Sciences (PRIVAK) were filed on 04-07-2024. You can view them here.

How many employees does Kbc Private Partners Life Sciences (PRIVAK) have?

There are currently no employees working at Kbc Private Partners Life Sciences (PRIVAK) or no workforce information is available.

What is the annual turnover of Kbc Private Partners Life Sciences (PRIVAK)?

At the time of its most recent financial statements, Kbc Private Partners Life Sciences (PRIVAK) did not publish any turnover figures. Kbc Private Partners Life Sciences (PRIVAK) reported a gross margin of -€7,831.17.